ApprovalTrail

Approval · Notice of Compliance 4224 · 1996

ZITHROMAX: Notice of Compliance 4224

Issued November 19, 1996

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
4224
Date
November 19, 1996
Company
Pfizer Canada UlcKirkland, Quebec, Canada
Product type
Prescription Pharmaceutical
Submission
Supplement to a New Drug Submission (SNDS), supplement
Submission class
Other
Reason
New indication
Therapeutic class
Antibiotic

Products in this notice

BrandDINStatus today
ZITHROMAXNot yet assigned—

Medicinal ingredients